abbott

Y-Logimed is the exclusive distributor of Abbott Vascular in Greece.

We collaborate with scientists, health care professionals and patients to provide life-changing cardiovascular technologies that offer efficient and effective disease management for a range of cardiac and vascular diseases. From heart and vascular stents to vessel closure devices and specialty guide wires, our cardiovascular products are designed to help healthcare professionals reduce hospitalizations and improve patient quality of life for patients in Greece. In cooperation with Abbott Vascular, a pioneer in Cardiac & Vascular disease management, we provide exceptional education-training and clinical support for healthcare professionals on cardiovascular products and therapy solutions.

CORONARY Interventions

Our company provides treatment options for heart conditions by offering a growing product portfolio, leading the way to unparalleled patient outcomes during and long after percutaneous coronary interventions (PCI)

CE Marked -1-month DAPT indication for High Bleeding Risk Patients

 XIENCE SIERRA™ STENT provides:

  • Best-in-class deliverability 5
  • Expanded treatment options 6
  • Unparalleled safety

XIENCE Sierra™ Drug Eluting Stent System

HEMOSTASIS MANAGEMENT SOLUTIONS

Abbott is committed to providing hemostasis management solutions to help patients and hospitals thrive. Time management, patient and staff flow, hospital costs, and throughput can all impact overall hospital efficiency.

Our hemostasis management portfolio aims to drive hospital efficiency through:

  • Early ambulation7,8,9
  • Reducing patient length of stay5,8,9
  • Lowering complications6,7
  • Improving patient outcomes6,7
  • Optimizing nursing time8,9

 

Perclose™ ProStyle™ Suture-Mediated Closure and Repair (SMCR) System

Perclose ProGlide™ Suture-Mediated Closure (SMC) System

StarClose SE™ Vascular Closure System (VCS)

Prostar XL™ Percutaneous Vascular Surgical System (PVSS)

PERIPHERAL Interventions

Our company provides treatment options for vascular conditions by offering a growing product portfolio, leading the way to unparalleled patient outcomes during and long after percutaneous vascular interventions.

HEMOSTASIS MANAGEMENT SOLUTIONS

Abbott is committed to providing hemostasis management solutions to help patients and hospitals thrive. Time management, patient and staff flow, hospital costs, and throughput can all impact overall hospital efficiency.

Our hemostasis management portfolio aims to drive hospital efficiency through:

  • Early ambulation7,8,9
  • Reducing patient length of stay5,8,9
  • Lowering complications6,7
  • Improving patient outcomes6,7
  • Optimizing nursing time8,9

 

Perclose™ ProStyle™ Suture-Mediated Closure and Repair (SMCR) System
Perclose ProGlide™ Suture-Mediated Closure (SMC) System
StarClose SE™ Vascular Closure System (VCS)
Prostar XL™ Percutaneous Vascular Surgical System (PVSS)